TETERBORO, N.J., May 18, 2000
In the newly created position of Corporate Vice President, Business Development, Mr.
Finnegan will be responsible for building upon Quest Diagnostics market leadership
position and accelerating profitable growth. He will focus on identifying, assessing and
executing strategic transactions with a particular emphasis on targeted growth areas
including esoteric and genetic testing, medical information and direct-to-consumer
services. He will report directly to Kenneth W. Freeman, Chairman and Chief Executive
Officer.
Mr. Finnegan joined Quest Diagnostics as Vice President, Treasurer, in July 1997. He
will retain responsibility for investor relations until a successor is named.
Before joining Quest Diagnostics, Mr. Finnegan had been Assistant Treasurer at General
Signal Corporation in Stamford, Conn. He also worked on the corporate staffs of
International Paper Company and Texaco, Inc.
Quest Diagnostics is the nation's leading provider of diagnostic testing, information
and services with annualized revenues of more than $3 billion. The testing performed on
human specimens helps doctors diagnose, treat and monitor disease; enables employers to
detect workplace drug abuse; and supports pharmaceutical and biotechnology companies in
clinical trials of new therapeutics worldwide. Quest Informatics analyzes laboratory and
other medical data to help health care providers improve the care of patients. Additional
company information can be found on the Internet at: www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements involve
risks and uncertainties that could cause the outcome to be materially different. Certain
of these risks and uncertainties are listed in the Quest Diagnostics Incorporated 1999
Form 10-K and subsequent filings.